Alyeska Investment Group
CGTX icon

Alyeska Investment Group’s Cognition Therapeutics CGTX Stock Holding History

Alyeska Investment Group’s Portfolio CGTX Stock Details CGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-102,095
Closed -$138K – 607
2025
Q3 		$138K Buy
+102,095
New +$139K ﹤0.01% 577
2025
Q1 		– Sell
-500,000
Closed -$351K – 529
2024
Q4 		$351K Hold
500,000
– – ﹤0.01% 527
2024
Q3 		$234K Hold
500,000
– – ﹤0.01% 502
2024
Q2 		$830K Hold
500,000
– – ﹤0.01% 474
2024
Q1 		$910K Buy
+500,000
New +$1.03M 0.01% 417

Other funds holding CGTX

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $626M AUM 67.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $35.6M AUM 76.14% 1-Year Est. Return